ZHANG Yan, TU Jing, HUANG Hui. Study on the correlation between serum adiponectin and placental matrix metalloproteinase 9 in patients with gestational hypertension[J]. Journal of Clinical Medicine in Practice, 2017, (3): 96-98. DOI: 10.7619/jcmp.201703029
Citation: ZHANG Yan, TU Jing, HUANG Hui. Study on the correlation between serum adiponectin and placental matrix metalloproteinase 9 in patients with gestational hypertension[J]. Journal of Clinical Medicine in Practice, 2017, (3): 96-98. DOI: 10.7619/jcmp.201703029

Study on the correlation between serum adiponectin and placental matrix metalloproteinase 9 in patients with gestational hypertension

More Information
  • Objective To explore the relationship between the level of serum adiponectin and placental matrix metalloproteinase 9 (MMP-9) in patients with gestational hypertension.Methods According to the severity of disease,145 patients with gestational hypertension were divided into mild gestational hypertension group (n =72) and severe gestational hypertension group (n =73),and 60 healthy pregnant women at the same time were selected as control group.The levels of serum adiponectin and MMP-9 expression were compared among three groups.Results Compared with control group,the levels of serum adiponectin in gestational hypertension groups decreased significantly (P < 0.05).There was significant difference between gestational hypertension groups and control group in the positive rate of MMP-9 (P < 0.05 or P < 0.01).The positive rate of MMP-9 in severe gestational hypertension group was significantly lower than that in mild one and control group (P <0.01).The level of serum adiponectin was positively correlated with placental MMP-9 in the patients with gestational hypertension (r =0.71,P < 0.05).Conclusion The decrease of serum adiponectin and the decreased expression of MMP-9 in placenta may promote the occurrence and development of gestational hypertension.
  • Related Articles

    [1]CHANG Naiqi, ZHANG Yong. Expression levels of serum heat shock protein 70, osteopontin and matrix metalloproteinase-9 in patients with valvular heart disease and their correlations with cardiac function[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 45-50. DOI: 10.7619/jcmp.20244639
    [2]LIU Ying, DU Likun, HU Lingdan, DU Zhiqiang, CUI Jing. Expression and significance of matrix metalloproteinases and toll-like receptor 9 in patients with acute leukemia[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 120-123, 129. DOI: 10.7619/jcmp.20240984
    [3]ZHANG Lanfang, CHEN Xu, KUAI Jun, QIN Lei, YANG Yan, CHANG Tingmin. Effect of tegafur, gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones, matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 57-60, 65. DOI: 10.7619/jcmp.20241047
    [4]SUN Ling, LI Tantan, WU Xifeng, MEN Lijie, JIA Meiyan, LU Jun. Correlations of serum tissue inhibitor of metalloproteinases-1, matrix metalloproteinase-9 and vascular endothelial growth factor with degree of myelofibrosis in patients with myeloproliferative neoplasms[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 34-40. DOI: 10.7619/jcmp.20234037
    [5]SHAN Na, ZHAO Li, LIN Xiaodong. Predictive value of serum matrix metalloproteinase-9 and neurofilament light chain levels for cognitive impairment patients after first-onset ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 67-70, 90. DOI: 10.7619/jcmp.20230606
    [6]WANG Fei, SHI Meihong. Relationships of BTB/POZ domain-containing protein 7 and matrix metalloproteinase-9 expression with autoantibodies in labial gland tissues of patients with primary Sjögren's syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 98-102. DOI: 10.7619/jcmp.20220899
    [7]YUAN Shanqi, ZHAO Hongmin, WANG Xiaoye, ZHANG Xi′an, HOU Pengfei, LIU Zhanhui. Application analysis of carotid ultrasound combined with detections of vascular endothelial growth factor, matrix metalloproteinase-9 and hypersensitive C-reactive protein in the stability of atherosclerotic plaque[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 27-29, 33. DOI: 10.7619/jcmp.201917008
    [8]LU Jianjun, YI Liping, TUO Ya, QIAO Huizhen. Expression and clinical significance of matrix metalloproteinases-9 in tissues of endometrial carcinoma[J]. Journal of Clinical Medicine in Practice, 2014, (15): 63-65,69. DOI: 10.7619/jcmp.201415019
    [9]GAO Mingjun, QI Bo. Influence of irbesartan and amlodipine on carotid-femoral artery pulse wave velocity and serum matrix metalloproteinase-9 level in patients with primary hypertension[J]. Journal of Clinical Medicine in Practice, 2013, (23): 12-14,18. DOI: 10.7619/jcmp.201323004
    [10]ZHANG Yuhua, CAI Xiangzeng, GUO Minghe. Effects of Chuanxiongqin on serum high-sensitivity C-reactive protein, interleukin-6 and matrix metalloproteinases-9 in treating acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2013, (17): 78-80. DOI: 10.7619/jcmp.201317026
  • Cited by

    Periodical cited type(1)

    1. 吴双胜,苏健婷,董彦会,徐文婕,夏志伟,陈东妮,李述刚,宋逸,郭欣,杨鹏. 洪涝灾害灾后学校卫生防疫技术指南. 中国学校卫生. 2023(11): 1606-1609 .

    Other cited types(0)

Catalog

    Article views (251) PDF downloads (4) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return